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A B S T R A C T  
 
Probiotic bacteria can be beneficial to the gastrointestinal tract in the human body in numerous 
ways. Autoaggregation may play a key role in allowing probiotics to prevent pathogenic organisms 
from colonizing the intestinal system. Currently, scientific research does not account for the extent 
in which the autoaggregation capacities of probiotics may be influenced by carbohydrates. In this 
experiment, nine carbohydrate sources, including those with prebiotic qualities, were applied to 
eighteen strains of bacteria of the Lactobacillus genus. The experiment evaluated the 
autoaggregation abilities of the lactobacilli strains exposed to the carbohydrate treatments. 
Generally, no carbohydrates stimulated the autoaggregation of most strains of lactobacilli. 
However, experimental results confirmed the rapid autoaggregation of Lactobacillus acidophilus 
La-5 exposed to treatments of 2’-fucosyllactose. These experimental results are relevant in 
understanding how carbohydrates may indirectly impact how probiotics can prevent pathogens from 
colonizing the gastrointestinal tract within the human body.
 
 
 
INTRODUCTION 
Scientific research concerning the extent to which 
carbohydrates impact the aggregation of probiotic bacteria 
is lacking. Probiotics are traditionally regarded as “live 
microorganisms that when administered in adequate 
amounts confer health benefits on the host” (Bertazzoni et 
al., 2013). Scientific studies have confirmed the extent to 
which probiotic bacteria metabolize carbohydrates, but 
scientific evidence indicating how carbohydrates 
physically affect the aggregation of probiotic bacteria is 
virtually non-existent. Probiotic bacteria, including strains 
of Lactobacillus, can stimulate and regulate growing 
populations of bacteria beneficial to the vitality of the 
gastrointestinal tract of the human body. Research 
indicates that certain strains of Lactobacillus are known to 
convey probiotic benefits upon human consumption; they 
are commercially added to dairy products and dietary 
supplements. Autoaggregation may enable probiotic 
bacteria to prevent pathogenic organisms from colonizing  
 
 
along epithelial cells within gastrointestinal systems 
(Goh & Klaenhammer, 2010).  
Throughout the intestinal system, beneficial 
intestinal bacteria, including strains of lactobacilli, 
ferment oligosaccharides, short to medium length 
carbohydrate polymers. Prebiotics are conventionally 
defined as “non-digestible but fermentable 
oligosaccharides that are specifically designed to change 
the composition and activity of the intestinal microbiota 
with the prospect to promote the health of the host” 
(Blaut, 2002). Fructose and galactose are the main 
monosaccharides that compose fructooligosaccharides 
(FOS) and galactooligosaccharides (GOS), respectively, 
typically within the dietary fibers of food products. The 
literature documents much evidence for the benefits of 
prebiotics, including stimulated growth of lactobacilli 
within the human intestinal tract (Fanaro et al., 2005). 
Potentially instrumental in promoting the growth of 
intestinal bacteria, prebiotics are nutritional ingredients 
added to some brands of infant formula. Infant formula 
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contrasts from human milk in that its composition is based 
upon cow’s milk, lacking oligosaccharides vital to infantile 
intestinal health. Human milk oligosaccharides (HMOs) 
potentially have the ability to inhibit the adhesion of 
pathogenic bacteria to epithelial cell surfaces along the 
intestinal tract (Newburg et al., 2005; Barile & Rastall, 
2013). Since formula-fed infants are not exposed to the 
HMOs that breast-fed infants are, they are disadvantaged 
in producing strains of beneficial intestinal bacteria, such 
as lactobacilli, and potentially exposed to intestinal 
pathogens.  
Ultimately, prebiotics may potentially affect the 
means in which bacterial aggregation can prevent the 
colonization of pathogens along intestinal epithelial 
surfaces. Research has not yet accounted for the 
mechanisms of interactions that occur between 
lactobacilli and carbohydrates. We hypothesized that 
different carbohydrate sources affect the autoaggregation 
of different strains of lactobacilli. The following 
experiment examined the range of autoaggregation 
abilities of different strains of lactobacilli that are exposed 
to different carbohydrate sources. Evaluating the range of 
autoaggregation abilities of lactobacilli strains, as a 
whole, is crucial in understanding the autoaggregation 
capacities of selected probiotic strains. Future 
implications of this experiment may stimulate in-depth 
research concerning the dietary effects of known 
probiotics and further the engineering of prebiotic 
supplements as nutritional components of infant formula. 
 
 
LITERATURE REVIEW 
Probiotic organisms, upon consumption, positively 
affect the overall health of the host in numerous ways. The 
following are among the multiple genera of yeasts and 
bacteria that can act as probiotic organisms: Lactobacillus, 
Leuconostoc, Pediococcus, Bifidobacterium, 
Saccharomyces, and Enterococcus. Probiotic 
microorganisms belonging to the Lactobacillus genus 
consist of several strains of bacteria that produce lactic acid 
via anaerobic fermentation. Probiotic strains of lactobacilli 
can promote sustained populations of commensal bacteria 
that inhabit the gastrointestinal system (Servin & 
Conconnier, 2003). Products containing certain strains of 
lactobacilli as commercial probiotics are commonly 
administered as dietary supplements; the strains 
Lactobacillus rhamnosus GG, Lactobacillus acidophilus 
NCFM, Lactobacillus casei Shirota, and Lactobacillus 
reuteri MM53 are examples of lactobacilli that exhibit 
probiotic qualities and are commonly used as dietary 
supplements (Reid, 1999). Strains of lactobacilli 
effectively function as probiotics based upon their ability 
to thrive in the intestinal system, produce lactic acid, 
adhere along epithelial cell surfaces, and prevent the 
colonization of pathogenic organisms along the 
gastrointestinal tract.  
Universally notorious for causing intestinal infection 
and diarrhea, Campylobacter jejuni is a bacterial 
pathogen that initially adheres to the mucus-lined 
surfaces along the intestinal tract. A compilation of 
studies of Mexican children revealed that breast-feeding 
proves to be a viable solution for preventing 
campylobacter diarrhea (Ruiz-Palacios et al., 2003). 
Human milk contains large amounts of complex 
oligosaccharides, which can inhibit the colonization of 
Campylobacter jejuni in the intestinal system. HMOs are 
polymers consisting of two to twenty monosaccharides, 
or simple sugars; HMOs can function as receptors for the 
H(O) blood antigen. HMOs prevent colonizing 
Campylobacter jejuni by regulating the amount of H-2 
milk-specific antibodies available for pathogens to bind 
with. Observing that campylobacter binding to H-2 
antigens causes infection, an experiment hypothesized 
that campylobacter’s host receptor may contain 
carbohydrate components that enable them to receive 
blood group antigens (Ruiz-Palacios et al., 2003). 
According to the hypotheses set by Ruiz-Palacios et 
al., three sets of experiments were conducted. First, an 
experiment was conducted to determine whether 
fucosylated oligosaccharide fractions of human milk 
inhibit campylobacter from adhering to epithelial cells in 
vitro. Second, an experiment confirmed the nature of the 
host receptors. The third set of experiments determined 
whether fucosylated HMOs inhibit C. jejuni in the 
human intestinal system in vivo and whether the transfer 
of an H(O) antigen gene in mouse pups prevents 
colonization.  
As the initial sets of experiments consisted of a 
mouse model, the experimental results indicated that 
mice orally administered dosages of human milk 
oligosaccharides had significantly low intestinal 
colonization of Campylobacter. The second set of 
experimental results revealed that fractions of neutral 
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HMOs and 2’-fucosyllactose (2FL) inhibited higher 
percentages of pathogenic campylobacter strains than non-
pathogenic campylobacter strains. The final experimental 
results indicated that mice pups exposed to HMOs, which 
functioned as antigen-specific receptors, were less 
impacted by inoculated campylobacter than pups that were 
not exposed to HMOs. The experiment concluded that 
fucosylated structures are potentially critical features of 
human milk. It is presumed that 2FL competes with H-2 
antigens by binding to Campylobacter. The experiment 
warrants further research on how the H-2 antigen functions 
as prerequisites for colonization of campylobacter. 
Prebiotic carbohydrates are manufactured to imitate the 
abilities of HMOs (Espinosa et al,. 2007), such as 
potentially preventing pathogens from colonizing the 
gastrointestinal tract.  
Our study aims to acquire knowledge about the 
aggregation of lactobacilli strains rather than strains of 
campylobacter. Select strains of lactobacilli can form 
aggregates and demonstrate probiotic characteristics. 
Examining how such probiotic strains autoaggregate may 
provide more in-depth knowledge about how probiotics 
aggregate overall. Scientific evidence indicates potential 
prevention of intestinal infections when probiotic bacteria 
bind with pathogenic organisms; scientific evidence has 
attempted to link the ability of bacterial autoaggregation 
with the tendency of bacteria to coaggregate. Based upon 
this association with coaggregation, lactobacilli bacterial 
autoaggregation may also play a role in inhibiting 
pathogens from colonizing the intestinal tract; thus, it 
would be critical to examine what factors may influence 
autoaggregation. Carbohydrates, for instance, were factors 
of our experiment that were tested to determine their 
potential effects on lactobacilli autoaggregation in vitro. 
Autoaggregation of probiotic bacteria may reveal 
knowledge concerning how probiotics function when 
exposed to other factors, aside from pathogenic organisms.  
Prebiotics are non-digestible oligosaccharides that exit 
the small intestines to be fermented by intestinal bacteria, 
including certain strains of lactobacilli, found within the 
colon (Gibson et al., 2004). The fermentation of prebiotic 
carbohydrates contributes to the growth of lactobacilli 
strains, altering the intestinal microbiota. Glucose, 
galactose, maltose, fructose and lactose are examples of 
saccharides that compose oligosaccharides. Commonly 
manufactured prebiotics include FOS, GOS, polydextrose 
(PDX), and inulin. Dietary fibers within food products 
typically contain prebiotic carbohydrates such as FOS 
and GOS. Scientific research was conducted to confirm 
evidence of the benefits conveyed by prebiotics, 
including the stimulated growth of lactobacilli within the 
human intestinal tract (Fanaro et al., 2005).  
FOS and GOS have been shown to promote growth 
in select strains of lactobacilli in infant intestinal tracts. 
Prebiotics, such as FOS and GOS, are added to some 
infant formulas as substitutes for HMOs innate to breast 
milk (Knol et al., 2005). HMOs are instrumental in 
promoting the growth of intestinal lactobacilli via 
fermentation (Ruiz-Palacios et al., 2003). HMOs also 
impact the inhibition of intestinal pathogens. In several 
in vitro experiments, formulated mixtures of 90 % short-
chain galactooligosaccharides and 10 % long-chain 
fructooligosaccharides were intended to emulate the 
properties of neutral HMOs (Fanaro et al., 2005). 
Haarman and Knol performed two experiments 
where mixtures of long-chain FOS and short- chain GOS 
were supplemented in infant formula administered to 
term and preterm infants (Haarman & Knol, 2005). 
Collectively, the results from each experiment indicated 
large populations of lactobacilli and bifidobacteria had 
accumulated in the gastrointestinal tract of the term and 
preterm infants. Each experiment concluded that when 
supplemented in infant formula, long-chain FOS and 
short-chain GOS had the ability to emulate properties of 
HMOs innate in breast-milk. A major property of HMOs 
involves stimulating the growth of massive populations 
of bifidobacteria and strains of lactobacilli that 
potentially confer benefits upon infant immune and 
intestinal system. Aside from FOS and GOS, inulin is 
another carbohydrate whose prebiotic capabilities have 
been tested in numerous experiments. For instance, the 
ability of inulin to generate the growth of beneficial, 
intestinal bacteria has been studied in several 
experiments. In a 2004 study completed by Moro et al., 
experimental results witnessed increasing populations of 
bifidobacteria and lactobacilli species with the intestinal 
system of infants exposed to mixtures of inulin and GOS 
(Moro et. al, 2004). The experiment concluded that the 
mixture of GOS and inulin, alternatively manipulated 
instead of FOS, had the ability to stimulate lactobacilli 
strains that potentially conveyed nutritional benefits 
upon infant intestinal systems. 
Additionally, the experimental results each involved 
the reduction of pathogenic organisms that coincided 
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with the increase of beneficial intestinal bacteria in the 
infantile intestinal system (Haarman & Knol, 2005). Each 
of these experiments reported reduced populations of 
pathogenic Clostridia associated with increasing 
bifidobacteria along the gastrointestinal tract. These 
experiments concluded that FOS and GOS, supplemented 
in infant formula, may prove critical in preventing the 
colonization of intestinal pathogens similarly to HMOs 
innate to breast milk. Thus, it can be reasonably deduced 
that prebiotics can help g row beneficial organisms and 
prevent colonizing pathogens in the gastrointestinal 
system. However, my experiment sought gain scientific 
evidence indicating how carbohydrates, regardless of 
prebiotics or non-prebiotics, affect aggregation of 
probiotic bacteria. Bacterial aggregation, among other 
mechanisms of probiotics, was of interest in our 
experiment. Specifically, the potential effect of 
carbohydrates on the autoaggregation probiotic lactobacilli 
was most relevant to our study.  
In order to colonize and infect the intestinal systems, 
pathogenic organisms initially adhere along epithelial cell 
surfaces along the gastrointestinal tract. Adhesion to 
epithelial cell surfaces enables probiotic bacteria to thrive 
in the intestinal system, allowing them to potentially 
inhibit pathogens from colonizing the gastrointestinal tract. 
For this reason, adhesion is often regarded as an essential 
requirement in selecting effective probiotics (Holzapfel & 
Schillinger, 2002). Additionally, bacterial aggregation is a 
favorable trait in selecting effective probiotics; some 
probiotic bacteria can aggregate, or form bacterial clusters, 
which potentially excludes pathogens from adhering to 
mucous surfaces in the intestinal tract. Coaggregation, or 
the clustering of two or more different types of bacteria, 
can involve probiotic bacteria binding to pathogenic 
bacteria. Autoaggregation, or uniform clustering, of only 
probiotic bacteria may assist in preventing pathogenic 
adherence to epithelial surfaces and colonization of the 
gastrointestinal tract. 
Numerous bacterial strains of the Lactobacillus genus 
can autoaggregate. While scientific research vaguely 
accounts for the mechanisms of lactobacilli aggregation, 
scientific evidence attributes aggregation to the 
interactions between components of the cell surface and 
secreted proteins. The adhesion abilities of lactobacilli 
strains are relative to the hydrophobic components on their 
cell surfaces; yet, scientific data has revealed discrepancies 
indicating these hydrophobic components may impact the 
autoaggregation of lactobacilli strains (Goh & 
Klaenhammer, 2010). Collectively, adhesion, 
hydrophobicity, autoaggregation and coaggregation are 
all factors that may enable probiotic bacteria to inhibit 
pathogenic intestinal colonization. 
An experiment was conducted by to determine 
whether bacterial aggregation and cell surface 
hydrophobicity of dairy L. plantarum strains were 
accurate indications of their adhesion abilities and 
potential for competitive exclusion of intestinal 
pathogens (García-Cayuela et al., 2014). Among one-
hundred twenty-six L. plantarum isolated from raw goat 
milk, five of the fourteen rapidly autoaggregated strains 
expressed phenotypes for dense aggregation. In the 
coaggregation assays, all L. plantarum strains and 
pathogens experienced coaggregation, yet the extent of 
coaggregation was dependent of the lactobacilli and 
pathogenic strains manipulated. It was concluded that 
strains with the highest autoaggregation abilities and 
expressed aggregation phenotypes were the most likely 
to coaggregate. Initiated by negative charges, 
hydrophobic components on cell surfaces directly affect 
the cellular adherence abilities, varying among bacterial 
strains.  
However, it concluded that cellular hydrophobicity 
was not the most accurate means of indicating the 
autoaggregation of lactobacilli strains. The experiment 
concluded that lactobacilli strains’ adhesion to 
epithelial cells were not always correlated with the 
aggregation phenotype, coaggregation abilities, and 
hydrophobic properties of the cell’s surface (García-
Cayuela et al., 2014). Aggregation abilities and 
hydrophobicity may not be as significant as other 
factors involved in adhesion and pathogenic 
competition. In regards to adhesion, they are potentially 
more relevant to the survival of lactobacilli, especially 
probiotic strains, within the gastrointestinal tract. 
METHODOLOGY 
Bacterial strains and growth conditions  
Eighteen strains of Lactobacillus were manipulated 
in this experiment (Table 1). All tested bacteria were 
stored at -80 ºC prior to use. Lactobacilli were grown in 
de Man, Rogosa, Sharpe (MRS) broth under anaerobic 
atmosphere consisting of 90 % N2, 5% CO2, and 5 % H2, 
at 37 ºC for 24 hours. 
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Table 1 
Strains of Lactobacillus.  
MJM* Organism Strain 
4 Lactobacillus gasseri  ATCC 3333 
7 Lactobacillus acidophilus NCFM 
9 Lactobacillus rhamnosus ATCC 53103 
13 Lactobacillus johnsonii ATCC 11506 
39 Lactobacillus acidophilus ATCC 4356 
53 Lactobacillus rhamnosus ATCC 9595 
73 Lactobacillus salivarius subsp. salivarius ATCC 11741 
89 Lactobacillus johnsonii La-1 
90 Lactobacillus plantarum LP-66 
96 Lactobacillus acidophilus La-5 
108 Lactobacillus fermentum CECT5716 
110 Lactobacillus reuteri MM53 
149 Lactobacillus casei LB6 
155 Lactobacillus plantarum  LB12 
206 Lactobacillus crispatus CC1-1 
207 Lactobacillus crispatus JCM5810 
208 Lactobacillus gallinarum ATCC 33199 
209 Lactobacillus helviticus CNRZ32 
*MJM refers to the strain number from the culture collection of Prof. 
Michael J. Miller. 
Treatments with Carbohydrate Competitors 
Ten treatments were applied to each of eighteen 
strains of lactobacilli. The following nine carbohydrates 
were utilized at concentrations of 10 mg/mL: inulin, FOS, 
GOS, lactose, maltodextrin, PDX, glucose, 2FL, and 
mannose. Water was used as a control treatment. Aliquots 
of each strain (0.5 mL) were prepared in 1.5 mL 
microcentrifuge tubes. Cells were harvested by 
centrifugation at 3000 x g for 5 minutes, followed by the 
removal of the MRS supernatant and re-suspension in 0.5 
mL acetate buffer (50 mM, pH 4.0) via brief vortexing. 
Equal volumes of each competitor were added to their 
respectively labeled test tubes containing the eighteen 
strains. Each of the sets of test tubes was briefly vortexed, 
prompting additional suspension of the lactobacilli 
strains in contact with the carbohydrate sources. Strains 
were observed over 60 minutes, after which 
autoaggregation was assessed. 
Qualitative Assessment 
The visible extent of autoaggregation for the 
lactobacilli strains, or lack thereof, was qualitatively 
measured. In conjunction with autoaggregation, the 
pelleted formations of the bacterial cells were measured 
using an alphabetized scale. Positive (+) and negative (-
) symbols were used to indicate the extent of 
autoaggregation visibly demonstrated by strains of 
lactobacilli. The letters, “A” through “D” were used to 
alphabetically categorize pellet formation, ranging from 
minimal formation of bacterial debris to compact 
portions of aggregated bacteria or loose pellet layers 
that exhibited uniform autoaggregation. 
 
FINDINGS 
Observations for the autoaggregation of each 
Lactobacillus strain are provided in Table 2. Some 
variability occurred in the control treatments from day 
to day, although carbohydrate treatments were 
consistent with the control with minor variation. This is 
best exemplified in the alternating patterns of 
autoaggregation MJM 39 on Day 1 and Day 3 and the 
autoaggregation of MJM 108 only on Day 2. MJM 9 
autoaggregated in PDX faster than when exposed to the 
control treatment; however, replicated treatments did 
not result in MJM 9 autoaggregating faster in the PDX 
than in the control.  
MJM 96 autoaggregated in the presence of 2FL 
faster than with the given control of the experiment; 
MJM 96 autoaggregated to a substantial extent more so 
when exposed to 2FL than when exposed to the 
experimental control on that given day. Non-
aggregative strains showed no signs of autoaggregation 
in the midst of the carbohydrate treatments. 
  
 
i-ACES Vol. 1 No. 1 (2014) 
 
Table 2 
Autoaggregation of lactobacilli in the presence of soluble carbohydrates. 
    Day 1   Day 2   Day 3 
MJM*   CTRL   INU   FOS   GOS   CTRL   MAL   GLU   PDX   LAC   CTRL   2FL   MAN 
4  +++ B  +++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B 
7  +++ B  +++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B 
9  D 0.5  D 0.5  D 0.6  D 0.7  D 0.3  D 0.5  D 0.3  +++ C  D 0.4  D 0.5  D 0.5  D 0.3 
13  -  -  - A  -  -  -  -  -  -  -  -  - 
39  ++ B  ++ B  ++ B  ++ B  -  -  -  -  -  ++ B  ++ B  ++ B 
53  - A  - A  - A  -  -  - A  + A  - B  -  - A  - A  - A 
73  -  -  -  -  -  -  -  -  -  -  -  - 
89  + B  + B  + B  + B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B 
90  -  -  -  -  -  -  -  -  -  -  -  - 
96  ++ B  + B  + B  + B  ++ B  +++ B  +++ B  ++ B  + B  + B  +++ B  + B 
108  -  -  -  -  ++ B  ++ B  ++ B  ++ B  + B  -  -  - 
110  -  -  -  -  -  -  -  -  -  -  - A  - 
149  +++ C  +++ C  +++ C  +++ C  +++ B  +++ B  +++ B  +++ B  +++ B  D 0.2  D 0.3  D 0.2 
155  +++ B  +++ B  +++ B  +++ B  +++ B  ++ B  +++ B  +++ B  ++ B  +++ B  +++ B  +++ B 
206  -  -  -  -  -  -  -  -  -  -  -  - 
207  -  -  -  -  ++ B  ++ B  ++ B  ++ B  + B  -  -  - 
208  +  +  +  +  ++ B  ++ B  ++ B  ++ B  ++ B  ++ B  + B  + 
209   +   -   +   -   -   -   - B   +   -   -   -   - 
*MJM: refers to the strain number from the culture collection of Prof. Michael J. Miller 
CTRL: control; INU: inulin; FOS: fructooligosaccharide; GOS: galactooligosaccharide; MAL: maltodextrin; GLU: glucose; PDX: 
polydextrose; LAC: lactose; 2FL: 2’-fucosyllactose; MAN: mannose 
- : no visible aggregates were in the cell suspension 
+ : small uniform aggregates were in suspension; sand-like grains of cells in small clusters seen with careful observation 
++ : easily visible aggregates; formed clusters were distinct from supernatant or remaining suspension 
+++: large obvious aggregates visible, may or may not leave some turbidity in the supernatant fluid 
A: presence of a small pellet or powdery collection of cells that settled out; potentially debris or dead cells fallen out of 
suspension 
B: a relatively tightly-packed pellet that generally forms rapidly upon aggregation of cells 
C: a loose layer formed on the bottom of tube, indicative of aggregation in a loose network; some flocs remained in 
suspension 
D: full aggregation indicated by no turbidity in supernatant above pellet; indicative of uniform aggregation of cells that slowly 
migrated down and formed even separation from the surface. Followed by a number indicating the volume (mL) of the cell 
pellet as it settled  
 
No instruments were utilized to quantify the results, so 
it is understandable that the experimental observations 
demonstrated some variability between treatments due to 
the qualitative nature of the assessments used. Generally, 
the growth conditions and handling of lactobacilli may 
vary as experimental results were taken on different days; 
the variation of growth factors and handling of lactobacilli 
may have potentially influenced their capacities for 
autoaggregation. Mishandling of lactobacilli may have 
involved the mislabeling of different lactobacilli strains, 
pipetted disruptions of pelleted cells, and vortexing 
technique that created time lags in the autoaggregation of 
certain lactobacilli strains. In the case of MJM 39 and 
MJM 108, their autoaggregation most likely resulted 
from mislabeling of those bacterial samples or 
contamination in contact with the strains.  
The autoaggregation of MJM 9, when exposed to 
PDX, occurred more rapidly than the strain’s 
autoaggregation subject to the control treatment. The 
occurrence of MJM 9 to autoaggregate faster in contact 
with PDX rather than in the control treatment may have 
been determined based upon an erroneous observation of 
a mislabeled strain. Additional trials were most likely 
unable to replicate this rapid autoaggregation due to the 
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presence of potential contaminants. Regardless of MJM 9’s 
phenotypic traits for aggregation, MJM 9 was not 
prompted to aggregate faster with PDX treatments than 
with control treatments in the replicated trials.  
The autoaggregation of MJM 96 subjected to the 
control treatment occurred at a slower rate than the strain’s 
autoaggregation in the presence of 2FL. Additional trials 
resulted in the autoaggregation of MJM 96 in contact with 
2 FL at faster rates than the strain’s autoaggregation in the 
presence of control treatments. These trials further 
confirmed the presence of more dense aggregates of MJM 
96 in the concentrated 2FL treatments than those 
aggregates formed in the control treatments. As these 
replicated trials support the conclusion that 2FL promotes 
the aggregation of L. acidophilus La-5, further research is 
required to understand how 2FL interacts with this strain 
and what are the implications that their interactions have 
on the capacities to autoaggregate in in vivo systems.  
The experiment manipulated the following three 
strains of Lactobacillus acidophilus: NCFM (MJM 7), 
ATCC 4356 (MJM 39), and La-5 (MJM 96). While each 
strain was exposed to the 2FL treatments, MJM 96 
autoaggregated to a more compact extent than MJM 7 or 
MJM 39. Each of the strains formed tightly packed pallets 
that resulted from immediate autoaggregation. However, 
compared to MJM 7 and 39, MJM 96 formed large, clearly 
defined aggregates within the turbid supernatant fluid; the 
rapid autoaggregation of MJM 96 subject to 2FL 
treatments was confirmed in three trials. These 
experimental results indicated that carbohydrates can have 
more than just species-specific impacts on 
autoaggregation. As demonstrated by the autoaggregation 
of the probiotic MJM 7, 39, and 96 strains in 2FL 
treatments, carbohydrates may be able to assert strain-
specific affects the on bacterial autoaggregation. This 
conclusion is supported by the resulting immediate 
autoaggregation of MJM 96 when subject to 2FL 
treatments. 
As the extent of autoaggregation is dependent on a 
strain’s aggregation capacities, non-aggregative strains did 
not present any indication of being prompted to 
autoaggregate by any of the carbohydrate treatments. Non-
autoaggregative qualities may be expressed by lactobacilli 
considered to have probiotic effects. Regardless of whether 
lactobacilli were non-probiotic or derived from 
commercial probiotics, the prebiotic carbohydrates did not 
promote autoaggregative responses from known 
aggregative and known non-aggregative strains of 
Lactobacillus. This suggests that carbohydrates are 
unable to induce the autoaggregation of lactobacilli, 
regardless of probiotic or non-probiotic qualities are 
present.  
However, there are several limitations in the 
experimental design that may limit the applicability of 
these conclusions. A major limitation of the experiment 
involved the use of only 18 strains of lactobacilli to 
determine how carbohydrates collectively affect 
multiple strains of lactobacilli, in terms of 
autoaggregation. The autoaggregation, or lack thereof, 
of these select 18 strains of lactobacilli were used for 
generalizing how carbohydrates potentially influenced 
the autoaggregation of all probiotic lactobacilli strains. 
The range of autoaggregation responses, prompted by 
the prebiotic carbohydrates, were used for evaluating 
the extent in which all prebiotics are capable of 
influencing bacterial autoaggregation. Furthermore, a 
significant limiting factor involved the environment 
where the experiment occurred. As the experiment 
tested the autoaggregation for the lactobacilli strains 
exposed to carbohydrate treatments, the resulting 
aggregates formed clusters while exposed to in vitro 
conditions. In the laboratory setting, the lactobacilli 
strains and carbohydrates were contained in isolated 
environments until manipulated for experimental 
purposes. The autoaggregation of some strains may 
have been more or less likely to occur due to the 
presence or absence favorable conditions of the in vitro 
setting. Environmental conditions that are potentially 
conducive for the autoaggregation or even bacterial 
growth of certain lactobacilli strains include optimal pH 
measurements and temperatures, which were not 
manipulated in this study. The extent in which the 
bacteria autoaggregated in these conditions were 
projected for how these strains would autoaggregate in 
the gastrointestinal system.  
Experimental results from in vitro testing would not 
be indicative of any given strain’s ability to 
autoaggregate along epithelial surfaces along the 
intestinal tracts. In in vivo settings, strains of beneficial 
intestinal bacteria, or those originating from the 
Lactobacillus genus, would have more direct contact to 
numerous microorganisms that also inhabit the 
microbiota of the human gut. As such microorganisms 
were not present during the experimental trials, there 
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are no documented results that can account for how these 
such organisms may impact bacterial autoaggregation. 
These intestinal organisms may have a more dynamic 
impact on bacterial autoaggregation than that of the 
carbohydrate sources utilized in the experiment. 
 
CONCLUSIONS 
Generally, neither prebiotic carbohydrates, 
monosaccharides nor disaccharides significantly impacted 
the autoaggregation in aggregative or non-aggregative 
lactobacilli strains. While the majority of the carbohydrate 
sources did not promote the autoaggregation of most 
lactobacilli strains, 2FL prompted the rapid 
autoaggregation of Lactobacillus acidophilus La-5. There 
exists abundant research concerning how probiotics 
function while few scientific studies account for how 
autoaggregation might be a factor in how probiotics inhibit 
pathogens from colonizing the intestinal systems. We 
investigated the extent to which carbohydrates were 
limitations to the abilities of lactobacilli strains to 
autoaggregate. The rapid stimulation of Lactobacillus 
acidophilus La-5 to autoaggregate by 2FL contributes to 
the necessary research investigating the mechanisms 
involved with probiotic bacteria and carbohydrate 
interactions. Further research is necessary to understand 
the interactions of 2FL with this strain. This finding may 
warrant further research in interactions between probiotic 
bacteria and carbohydrates, perhaps with additional 
strains. If autoaggregation is a crucial element of efficient 
probiotics, further research is needed to investigate what 
factors affect autoaggregation. The experimental results, 
overall, warranted scientific research that focused on 
carbohydrates as potential, influential factors on the 
autoaggregation of lactobacilli strains. Modified 
experiments need to focus on factors that impact 
autoaggregation of probiotic bacteria in vivo, aside from 
isolated carbohydrates. 
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